Analysts Set DRI Healthcare Trust (TSE:DHT.UN) PT at C$18.25

DRI Healthcare Trust (TSE:DHT.UN) has received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is C$18.25.

Several brokerages have weighed in on DHT.UN. Truist Financial decreased their price objective on shares of DRI Healthcare Trust from C$17.00 to C$14.00 in a report on Thursday, July 25th. Scotiabank boosted their price objective on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th.

DRI Healthcare Trust Stock Performance

DHT.UN stock opened at C$13.17 on Friday. The stock’s 50 day moving average is C$13.18 and its two-hundred day moving average is C$13.70. DRI Healthcare Trust has a 52-week low of C$10.39 and a 52-week high of C$17.43.

DRI Healthcare Trust Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were issued a $0.085 dividend. This represents a $0.34 annualized dividend and a dividend yield of 2.58%. The ex-dividend date of this dividend was Friday, September 27th. DRI Healthcare Trust’s dividend payout ratio (DPR) is -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.